Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 076919

Expand all

LEVETIRACETAM (LEVETIRACETAM)
500MG
Marketing Status: Prescription

Active Ingredient: LEVETIRACETAM
Proprietary Name: LEVETIRACETAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076919
Product Number: 002
Approval Date: Nov 4, 2008
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

LEVETIRACETAM (LEVETIRACETAM)
750MG
Marketing Status: Prescription

Active Ingredient: LEVETIRACETAM
Proprietary Name: LEVETIRACETAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 750MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076919
Product Number: 003
Approval Date: Nov 4, 2008
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

LEVETIRACETAM (LEVETIRACETAM)
250MG
Marketing Status: Discontinued

Active Ingredient: LEVETIRACETAM
Proprietary Name: LEVETIRACETAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A076919
Product Number: 001
Approval Date: Nov 4, 2008
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information